Meridian Launches Two New Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Saliva Samples
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has launched its new Air-Dryable Direct DNA qPCR Saliva and Air-Dryable Direct RNA/DNA qPCR Saliva Mixes, which are designed for incorporation in room-temperature stable molecular assays, directly targeting nucleic acid sequence from saliva and sputum. More...08 Sep 2021
Global COVID-19 Saliva-Based Screening Market to Continue Growing Due to Ease of Use and Shorter Test-to-Result
The global COVID-19 saliva-based screening market was valued at over USD 1.7 billion in 2020 and is gaining traction, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. More...07 Sep 2021
New Microchip-Based Diagnostic System Rapidly Measures Amount of SARS-CoV-2 Antibodies in Blood
Researchers have developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19. More...03 Sep 2021
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
FLU/RSV Test
Humasis FLU/RSV Combo
In Other News
Low Cost Portable Genomic Sequencing Platform to Help Labs in Developing Countries Track SARS-CoV-2 Variants
First-of-Its-Kind End-to-End Digital Health Platform Automates and Simplifies Diagnostic COVID-19 Testing Experience
Rapid Antigen Testing for SARS-CoV-2 Could Effectively Control COVID-19 Outbreak, Finds Study
Dipstick-Based Test Enables Rapid Genetic Fingerprinting of SARS-Cov-2 Variants
Testing Saliva as Reliable as Nasal Swab and Detects 93% of COVID-19 Infections, Finds Study
Qiagen and GT Molecular Offer Wastewater Workflow Solution for Surveillance of COVID-19 Outbreaks
Triple COVID-19 Antibody Testing Device Indicates Prior SARS-CoV-2 Infection and If Your Vaccine Worked
Fujirebio Europe Receives CE Marking for Fully Automated Lumipulse G SARS-CoV-2 S-IgG Assay
New Ultrarapid COVID-19 Test Gives Highly Accurate Results Faster than PCR and LAMP Tests
Infra-Red Technology Based Test Can Rapidly Predict Severe COVID-19
New Electrochemical COVID-19 Test Uses Pencil Lead to Deliver 100% Accurate Results from Saliva Samples
New CRISPR-Based Technology Could Revolutionize COVID-19 Diagnostics
New Faster COVID-19 Test Avoids RNA Degradation and Time-Consuming Extraction
Bio-Rad Launches SARS-CoV-2 S Gene Alpha, Beta, Gamma, and Epsilon Variant Controls
Impedance Analyzer Connected to DNA Biosensor Enables Ultra-Fast and Cheap Detection of SARS-CoV-2
New Platform That Quickly Identifies Common SARS-CoV-2 Mutations Could Pave Way for Tailored Antibody Treatments
DiaCarta’s New Molecular COVID 19 Test Screens for SARS-CoV-2 and Simultaneously Identifies Delta Plus and New Variants
Low-Cost Tabletop Device Detects SARS-CoV-2 Variants from Saliva Sample in an Hour
QIAGEN’s Rapid and Portable QIAreach SARS CoV-2 Antigen Test Receives US FDA Emergency Use Authorization
New CRISPR-Based Test That Is Much Faster and Easier to Deploy than qRT-PCR Diagnoses COVID-19 in 20 Minutes
Blood Test for Specific and Sensitive Biomarker Can Predict Which Patients Will Develop COVID-19 Symptoms
LumiraDx SARS-CoV-2 Ab Test Receives FDA EUA, Allowing COVID-19 Antigen and Antibody Testing on Single POC Platform
ELITechGroup Receives CE Mark for Saliva on SARS-CoV-2 ELITe MGB Kit
